NextCell publishes its Year-End Report 2022/2023
NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Year-End Report for the period September 1, 2022 – August 31, 2023. The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.Fourth quarter (2023-06-01 until 2023-08-31) ● Operating Income amounted to 3,947 (1,405) TSEK.● Net Income for Cellaviva amounted to 2,758 (1,359) TSEK.● Operating result amounted to